v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash Flows from Operating Activities            
Net income       $ 32,913 $ 23,516  
Adjustments to reconcile net income to net cash from operating activities:            
Depreciation       2,971 2,999  
Amortization (accretion) of premiums and discounts on available-for-sale securities, net       (381) 89  
Capitalized additions to servicing rights       (1,059) (828)  
Servicing rights amortization and impairment $ 349   $ 586 1,200 947  
Amortization of core deposit intangible       822 1,242  
Amortization of customer list intangible       92 92  
Net accretion of fair value adjustments       (783) (1,816)  
Amortization of subordinated note issuance costs       67 86  
Stock-based compensation expense       1,016 1,077  
Director stock awards       255 189  
Provision for credit losses - loans (104)   557 371 2,029 $ 2,596
Provision for (recovery of) credit losses - off balance sheet credit exposures 479   (272) 633 (505)  
Gain on sale of loans held for sale (399)   (444) (1,657) (985)  
Originations of loans held for sale       (70,956) (44,991)  
Proceeds from sale of loans held for sale       74,020 45,969  
(Gain) loss on derivatives       75 (45)  
(Gain) loss on sale of other assets owned (1)   0 (31) 39  
Loss on sales of securities available-for-sale       347 0  
Increase in cash surrender value of bank owned life insurance       (2,067) (730)  
Change in other assets and other liabilities, net       (4,535) (5,061)  
Net cash provided by operating activities       33,313 23,313  
Activity in available-for-sale securities:            
Maturities, prepayments and calls       64,867 49,368  
Sales   $ 5,400   5,354 1,374  
Purchases       (112,626) (32,825)  
Activity in other securities, at cost:            
Purchases of FHLB stock       (521) (1,026)  
Proceeds from redemption of FHLB stock       2,872 3,917  
Purchase of bank owned life insurance       (2,500) 0  
Proceeds from bank owned life insurance       3,226 0  
Change in interest-bearing time deposits       980 984  
Proceeds from sale of other assets owned       985 15  
Additions to premises and equipment       (1,157) (1,580)  
Net increase on loan originations and principal collections       (25,319) (96,000)  
Net cash used in investing activities       (63,839) (75,773)  
Cash Flows from Financing Activities            
Net change in deposits       231,757 65,146  
Net change in federal funds purchased and securities sold under agreements to repurchase       (22,550) (4,500)  
Proceeds from FHLB advances       32,180 0  
Repayment of FHLB advances       (91,664) (58,153)  
Purchase of treasury stock       (1,721) (361)  
Cash dividends paid on common stock       (9,383) (8,993)  
Net cash provided by (used in) financing activities       138,619 (6,861)  
Net Increase (Decrease) in Cash and Cash Equivalents       108,093 (59,321)  
Cash and Cash Equivalents - Beginning of year   $ 97,718   97,718 176,351 176,351
Cash and Cash Equivalents - End of period $ 205,811   $ 117,030 205,811 117,030 $ 97,718
Supplemental cash flow information:            
Interest paid       50,012 53,320  
Federal income taxes paid       9,100 6,510  
State income taxes paid       445 177  
Supplemental noncash disclosures:            
Transfer of loans to other real estate owned       319 0  
Cash dividends declared not paid       $ 3,399 $ 3,091